Biotech Values

[DewDiligence]

>> I will continue to investigate whether I am quite busy at this time and report to you. <<

Thanks. I’m looking forward to your analysis whenever you get a chance.

BTW: if I thought AdPEDF were the real deal, I’d be inclined to take a position in GNVC, which is a pretty cheap stock. But given the radical nature of the product, I see AdPEDF having to traverse a bumpy road to get to FDA approval.